Skip to main content
Enass H. Raffa on Muck Rack

Enass H. Raffa

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Enass H.

Contact Enass H., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Can pre-transplant sickle cell disease characteristics predict early post-transplant complications?

|
By Mohamed Salaheldin Bayoumy, Enass H. Raffa, Amal Alseraihy, Amany Orabe, Hassan A Altrabolsi, Shady A Kamel, Alaa Kintab, Ibraheem Abosoudah, Shaker Abdulla, Rania Jaha, Wasil Jastaniah
| Nature Verified
Hematopoietic stem cell transplantation (HSCT) remains the only established curative therapy for sickle cell disease (SCD). Despite advances in conditioning, donor selection, and supportive care, the early post-transplant period remains associated with substantial risks of acute toxicity, infection, and early mortality [1,2,3,4]. Identifying patients at increased risk for early complications remains an unmet need in SCD transplantation.
Open in Who Shared Issue with article?

Outcomes of Hematopoietic Stem Cell Transplantation in children with Sickle Cell Disease: Does donor Sickle cell trait status matter? - Bone Marrow Transplantation

|
By Mohamed Salaheldin Bayoumy, Amany Orabe, Enass H. Raffa, Amal Alseraihy Alharbi
| Nature Verified
Sickle cell disease (SCD) encompasses a group of inherited blood disorders caused by mutations in the beta-globin gene, resulting in the production of abnormal hemoglobin S (HbS). SCD is particularly prevalent in Saudi Arabia, with carrier rates as high as 27%, largely attributed to consanguineous marriages [1, 2]. SCD consists of various genetic forms, including homozygous HbSS, HbSC and compound heterozygous HbS-B0/+ states, all of which contribute to significant morbidity and mortality [3].
Open in Who Shared Issue with article?
See all 2 articles